The growing evidence for targeting P-glycoprotein in lysosomes to overcome resistance.

Autor: Stefan SM; Molecular Pharmacology & Pathology Program, Department of Pathology & Bosch Institute, The University of Sydney, Sydney, NSW 2006, Australia., Jansson PJ; Molecular Pharmacology & Pathology Program, Department of Pathology & Bosch Institute, The University of Sydney, Sydney, NSW 2006, Australia., Kalinowski DS; Molecular Pharmacology & Pathology Program, Department of Pathology & Bosch Institute, The University of Sydney, Sydney, NSW 2006, Australia., Anjum R; Molecular Pharmacology & Pathology Program, Department of Pathology & Bosch Institute, The University of Sydney, Sydney, NSW 2006, Australia., Dharmasivam M; Molecular Pharmacology & Pathology Program, Department of Pathology & Bosch Institute, The University of Sydney, Sydney, NSW 2006, Australia., Richardson DR; Molecular Pharmacology & Pathology Program, Department of Pathology & Bosch Institute, The University of Sydney, Sydney, NSW 2006, Australia.
Jazyk: angličtina
Zdroj: Future medicinal chemistry [Future Med Chem] 2020 Mar; Vol. 12 (6), pp. 473-477. Date of Electronic Publication: 2020 Feb 26.
DOI: 10.4155/fmc-2019-0350
Databáze: MEDLINE